Amy Beck

4.9k citations

33 papers · 2.6k indexed · 1 hit paper · h-index 21

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis

Papers in ⓘ

Oncology 16
- Peptidase Inhibition and Analysis 4
- HER2/EGFR in Cancer Research 2
Biological Psychiatry 1

Co-authors: Paulette Mhawech‐Fauceglia (16 shared papers)Kunle Odunsi (15 shared papers)Shashikant Lele (12 shared papers)Feng Qian (4 shared papers)Sacha Gnjatic (5 shared papers)Lloyd J. Old (5 shared papers)Junko Matsuzaki (5 shared papers)Austin Miller (5 shared papers)
Journals: European Journal of Surgical Oncology (3 papers)PLoS ONE (3 papers)Proceedings of the National Academy of Sciences (2 papers)Modern Pathology (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Switzerland France

In The Last Decade

Amy Beck

32 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer 2010 · 695 citations

Peers

Countries citing papers authored by Amy Beck

Since Specialization

Citations

This map shows the geographic impact of Amy Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Beck more than expected).

Fields of papers citing papers by Amy Beck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Beck. The network helps show where Amy Beck may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Beck Line = papers co-authored together Amy Beck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer Proceedings of the National Academy of Sciences ·Junko Matsuzaki, Sacha Gnjatic, Paulette Mhawech‐Fauceglia, Amy Beck, Austin Miller, Takemasa Tsuji, Cheryl Eppolito, Feng Qian, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Kunle Odunsi Hit paper breakdown →	2010	695
2	Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism PLoS ONE ·Jianqun Liao, Feng Qian, Nana Tchabo, Paulette Mhawech‐Fauceglia, Amy Beck, Qian Zikun, Xinhui Wang, Wendy J. Huss, Shashikant Lele, Carl Morrison, Kunle Odunsi	2014	290
3	NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. PubMed ·Kunle Odunsi, Achim A. Jungbluth, Elisabeth Stockert, Feng Qian, Sacha Gnjatic, Jonathan Tammela, Marilyn Intengan, Amy Beck, Bernadette Keitz, Darren Santiago, Barbara Williamson, Matthew J. Scanlan, Gerd Ritter, Yao‐Tseng Chen, Deborah Driscoll, Ashwani Sood, Shashikant Lele, Lloyd J. Old	2003	208
4	Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer Cancer Immunology Research ·Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech‐Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf	2014	153
5	Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients Proceedings of the National Academy of Sciences ·Kunle Odunsi, Junko Matsuzaki, Julia Karbach, Antje Neumann, Paulette Mhawech‐Fauceglia, Austin Miller, Amy Beck, Carl D. Morrison, Gerd Ritter, Heidi Godoy, Shashikant Lele, Nefertiti C. duPont, Robert P. Edwards, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic, Elke Jäger	2012	148
6	Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer Cancer Research ·Feng Qian, Jeannine Villella, Paul K. Wallace, Paulette Mhawech‐Fauceglia, Joseph D. Tario, Chris Andrews, Junko Matsuzaki, Danila Valmori, Maha Ayyoub, Peter J. Frederick, Amy Beck, Jianqun Liao, Richard Cheney, Kirsten B. Moysich, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Kunle Odunsi	2009	118
7	MCM2 Is an Independent Predictor of Survival in Patients With Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Nithya Ramnath, F.J. Barbado Hernández, Dongfeng Tan, Joel A. Huberman, Nachimuthu Natarajan, Amy Beck, Andrew Hyland, Иван Тодоров, John S. Brooks, Gerold Bepler	2001	118
8	Genomic Analysis of Human Chromosome 10q and 4q Telomeres Suggests a Common Origin Genomics ·Michel van Geel, Morag C. Dickson, Amy Beck, Daniel J. Bolland, Rune R. Frants, Silvère M. van der Maarel, Pieter J. de Jong, Jane Hewitt	2002	105
9	MCM2 - a promising marker for premalignant lesions of the lung: a cohort study BMC Cancer ·DongFeng Tan, Joel A. Huberman, Andrew Hyland, Gregory Loewen, John S. Brooks, Amy Beck, Иван Тодоров, Gerold Bepler	2001	74
10	Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer Gynecologic Oncology ·Bonnie H. Hylander, Elizabeth A. Repasky, Protul Shrikant, Marilyn Intengan, Amy Beck, Deborah Driscoll, Pankaj Singhal, Shashikant Lele, Kunle Odunsi	2005	69
11	HER-2/ neu Protein Expression and Gene Alteration in Stage I-IIIA Non???Small-Cell Lung Cancer: A Study of 140 Cases Using a Combination of High Throughput Tissue Microarray, Immunohistochemistry, and Fluorescent In Situ Hybridization Diagnostic Molecular Pathology ·Dongfeng Tan, George Deeb, Jianmin Wang, Harry K. Slocum, Janet S. Winston, Sam M. Wiseman, Amy Beck, Sheila N.J. Sait, Timothy Anderson, Chukwumere Nwogu, Nithya Ramnath, Gregory Loewen	2003	66
12	Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry Modern Pathology ·George Deeb, Jianmin Wang, Nithya Ramnath, Harry K. Slocum, Sam M. Wiseman, Amy Beck, Dongfeng Tan	2004	62
13	Diagnostic utility of FLI‐1 monoclonal antibody and dual‐colour, break‐apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI‐1 polyclonal antibodies Histopathology ·Paulette Mhawech‐Fauceglia, François R. Herrmann, Remedios Penetrante, Amy Beck, Sheila Sait, Anne Marie W. Block, Kunle Odunsi, J E Fisher, Lucia Balos, Richard T. Cheney	2006	61
14	Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer PLoS ONE ·Sayeema Daudi, Kevin H. Eng, Paulette Mhawech‐Fauceglia, Carl D. Morrison, Anthony Miliotto, Amy Beck, Junko Matsuzaki, Takemasa Tsuji, Adrienne Groman, Sacha Gnjatic, Guillo Spagnoli, Shashikant Lele, Kunle Odunsi	2014	57
15	FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer European Journal of Surgical Oncology ·Paulette Mhawech‐Fauceglia, Richard T. Cheney, Gabor Fischer, Amy Beck, François R. Herrmann	2006	57
16	Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro PLoS ONE ·Kunle Odunsi, Paulette Mhawech‐Fauceglia, Chris Andrews, Amy Beck, Olajumoke Amuwo, Shashikant Lele, Jennifer D. Black, Ruea-Yea Huang	2012	40
17	Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. PubMed ·Nana Tchabo, Paulette Mhawech‐Fauceglia, Otávia L. Caballero, Jeannine Villella, Amy Beck, Anthony Miliotto, Jianqun Liao, Chris Andrews, Shashikant Lele, Lloyd J. Old, Kunle Odunsi	2009	40
18	Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up European Journal of Surgical Oncology ·Paulette Mhawech‐Fauceglia, Gabor Fischer, Amy Beck, Richard T. Cheney, François R. Herrmann	2006	33
19	Prognostic Significance of Molecular Genetic Aberrations on Chromosome Segment 11p15.5 in Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Gerold Bepler, Ashish Gautam, Lauren M. McIntyre, Amy Beck, David S. Chervinsky, Youngchul Kim, Diana M. Pitterle, Andrew Hyland	2002	29
20	Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy Journal of Clinical Pathology ·Paulette Mhawech‐Fauceglia, Pavel Dulguerov, Amy Beck, Marta Bonet, Abdelkarim S. Allal	2006	26

About Amy Beck

Amy Beck is a scholar working on Oncology, Biological Psychiatry, Immunology, Molecular Biology and Behavioral Neuroscience, having authored 33 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), RNA modifications and cancer (4 papers), Peptidase Inhibition and Analysis (4 papers), RNA Interference and Gene Delivery (3 papers), Lung Cancer Treatments and Mutations (3 papers), Medical Imaging and Pathology Studies (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.3k citations), Biological Psychiatry (76 citations), Reproductive Medicine (174 citations) and Cancer Research (293 citations). Amy Beck has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Paulette Mhawech‐Fauceglia, Kunle Odunsi, Shashikant Lele, Feng Qian, Sacha Gnjatic, Lloyd J. Old, Junko Matsuzaki, Austin Miller, Protul Shrikant and Takemasa Tsuji. Their work appears in journals such as European Journal of Surgical Oncology, PLoS ONE, Proceedings of the National Academy of Sciences, Modern Pathology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact